REGISTERED CHARITY NUMBER: 1182494
Report of the Trustees and
Unaudited Financial Statements
for the Year Ended 5 April 2024
for
BRITISH COCHLEAR IMPLANT GROUP CIO
Sandison Lang Limited
2 St Marys Road
Tonbridge
Kent
TN9 2LB
BRITISH COCHLEAR IMPLANT GROUP CIO
Contents of the Financial Statements
for the Year Ended 5 April 2024
|
Page |
Report of the Trustees |
1 to 2 |
Independent Examiner's Report |
3 |
Statement of Financial Activities |
4 |
Balance Sheet |
5 |
Notes to the Financial Statements |
6 to 10 |
Detailed Statement of Financial Activities |
11 to 12 |
BRITISH COCHLEAR IMPLANT GROUP CIO
Report of the Trustees
for the Year Ended 5 April 2024
The trusteespresenttheirreportwith the financialstatementsof the charityfor the yearended 5 April 2024.
ThetrusteeshaveadoptedtheprovisionsofAccountingandReportingbyCharities:Statement of
RecommendedPracticeapplicabletocharitiespreparingtheiraccountsinaccordancewiththe Financial
Reporting Standard applicable in the UK and Republic of Ireland (FRS 102) (effective 1 January 2019).
OBJECTIVES AND ACTIVITIES
Objectives and aims
For the public benefit to advanceknowledge,best practiceand awarenessin the field of hearing implantation,
in particularthroughthedisseminationofcochlearimplantresearchtohealthprofessionalsand information
tothepublicin ordertoimprovehearing,communicationandqualityoflifeofhearing-impairedpeople and
their families.
Significant activities
We as Charityto provideinformationto all professionalsand implantrecipients.We haveannual conference
andsomewebinarsessions.Weattendotherconferencestoincreasedtheawarenessofcochlear implants.
Wehaveatleastoncefacetofacemeetinginoneyearandseveralonlinemeetings.Weaccept job
advertisement.
STRUCTURE, GOVERNANCE AND MANAGEMENT
Governing document
Thecharityiscontrolledbyitsgoverningdocument,adeedoftrustandconstitutesan unincorporated
charity.
REFERENCE AND ADMINISTRATIVE DETAILS
Registered Charity number
1182494
Principal address
Yorkshire Auditory Implant Service
Bradford Royal Infirmary
Duckworth Lane
Bradford
BD9 6RJ
Trustees
Professor M Bance
E Stapleton
J Gallacher
J Townsend
Dr Y Guo (appointed 14.4.2023)
R McTaggart (appointed 14.4.2023)
C Killan (appointed 14.4.2023)
H Meakin
A Banerjee
C Totten (appointed 14.4.2023)
Page 1
BRITISH COCHLEAR IMPLANT GROUP CIO
Report of the Trustees
for the Year Ended 5 April 2024
REFERENCE AND ADMINISTRATIVE DETAILS
Independent Examiner
Sandison Lang Limited
2 St Marys Road
Tonbridge
Kent
TN9 2LB
Approved by order of the board of trustees on 11 February 2025 and signed on its behalf by:
Dr Y Guo - Trustee
Page 2
Independent Examiner's Report to the Trustees of
British Cochlear Implant Group CIO
Independent examiner's report to the trustees of British Cochlear Implant Group CIO
I reportto the charitytrusteeson my examinationof the accountsof BritishCochlearImplantGroupCIO (the
Trust) for the year ended 5 April 2024.
Responsibilities and basis of report
As the charitytrusteesof the Trust you are responsiblefor the preparationof the accountsin accordance with
the requirements of the Charities Act 2011 ('the Act').
I reportin respectofmyexaminationoftheTrust'saccountscarriedoutunderSection145oftheActand in
carryingoutmyexaminationI havefollowedall applicableDirectionsgivenby the CharityCommission under
Section 145(5)(b) of the Act.
Independent examiner's statement
Ihavecompletedmyexamination.Iconfirmthatnomaterialmattershavecometomyattention in
connection with the examination giving me cause to believe that in any material respect:
1. accounting records were not kept in respect of the Trust as required by Section 130 of the Act; or
2. the accounts do not accord with those records; or
3. the accounts do not comply with the applicable requirements concerning the form and content of accounts set out in the Charities (Accounts and Reports) Regulations 2008 other than any requirement that the accounts give a true and fair view which is not a matter considered as part of an independent examination.
Ihavenoconcernsandhavecomeacrossnoothermattersinconnectionwiththeexaminationto which
attentionshouldbedrawninthisreportinordertoenableaproperunderstandingoftheaccountsto be
reached.
Mr Ryan Cottington ACA
Sandison Lang Limited
2 St Marys Road
Tonbridge
Kent
TN9 2LB
11 February 2025
Page 3
BRITISH COCHLEAR IMPLANT GROUP CIO
Statement of Financial Activities
for the Year Ended 5 April 2024
|
|
2024 |
2023 |
|
|
Unrestricted |
|
|
|
fund |
Total funds |
|
Notes |
£ |
£ |
INCOME AND ENDOWMENTS FROM |
|
|
|
Donations and legacies |
|
27,071 |
31,781 |
Other trading activities |
2 |
- |
3,000 |
Investment income |
3 |
155 |
28 |
Total |
|
27,226 |
34,809 |
EXPENDITURE ON |
|
|
|
Raising funds |
4 |
- |
25,369 |
Other |
|
45,594 |
36,191 |
Total |
|
45,594 |
61,560 |
NET INCOME/(EXPENDITURE) |
|
(18,368) |
(26,751) |
RECONCILIATION OF FUNDS |
|
|
|
Total funds brought forward |
|
146,178 |
172,929 |
TOTAL FUNDS CARRIED FORWARD |
|
127,810 |
146,178 |
The notes form part of these financial statements
Page 4
BRITISH COCHLEAR IMPLANT GROUP CIO
Balance Sheet
5 April 2024
|
|
2024 |
2023 |
|
|
Unrestricted |
|
|
|
fund |
Total funds |
|
Notes |
£ |
£ |
CURRENT ASSETS |
|
|
|
Cash at bank |
|
128,644 |
146,864 |
CREDITORS |
|
|
|
Amounts falling due within one year |
7 |
(834) |
(686) |
NET CURRENT ASSETS |
|
127,810 |
146,178 |
TOTAL ASSETS LESS CURRENT LIABILITIES |
|
127,810 |
146,178 |
NET ASSETS |
|
127,810 |
146,178 |
FUNDS |
8 |
|
|
Unrestricted funds |
|
127,810 |
146,178 |
TOTAL FUNDS |
|
127,810 |
146,178 |
ThefinancialstatementswereapprovedbytheBoardofTrusteesandauthorisedforissue on
11 February 2025 and were signed on its behalf by:
Y Guo - Trustee
The notes form part of these financial statements
Page 5
BRITISH COCHLEAR IMPLANT GROUP CIO
for the Year Ended 5 April 2024
Notes to the Financial Statements
1. ACCOUNTING POLICIES
Basis of preparing the financial statements
Thefinancialstatementsofthecharity,whichisapublicbenefitentityunderFRS102,have been
preparedinaccordancewiththeCharitiesSORP(FRS102)'AccountingandReportingby Charities:
StatementofRecommendedPracticeapplicabletocharitiespreparingtheiraccountsin accordance
withthe FinancialReportingStandardapplicablein the UK and Republicof Ireland(FRS102) (effective
1 January2019)',FinancialReportingStandard102'TheFinancialReportingStandardapplicablein the
UKandRepublicofIreland'andtheCharitiesAct2011.Thefinancialstatementshavebeen prepared
under the historical cost convention.
Income
All incomeis recognisedin the Statementof FinancialActivitiesonce the charityhas entitlementto the
funds, it is probable that the income will be received and the amount can be measured reliably.
Expenditure
Liabilitiesarerecognisedasexpenditureassoonasthereisalegalorconstructive obligation
committingthecharitytothatexpenditure,itisprobablethatatransferofeconomicbenefitswill be
requiredinsettlementandtheamountoftheobligationcanbemeasuredreliably.Expenditure is
accountedforonanaccrualsbasisandhasbeenclassifiedunderheadingsthataggregateall cost
relatedtothecategory.Wherecostscannotbedirectlyattributedtoparticularheadingsthey have
been allocated to activities on a basis consistent with the use of resources.
Taxation
The charity is exempt from tax on its charitable activities.
Fund accounting
Unrestrictedfundscanbeusedinaccordancewiththecharitableobjectivesatthediscretionof the
trustees.
Restrictedfundscanonlybeusedforparticularrestrictedpurposeswithintheobjectsofthe charity.
Restrictionsarisewhenspecifiedbythedonororwhenfundsareraisedforparticular restricted
purposes.
Furtherexplanationofthenatureandpurposeofeachfundisincludedinthenotestothe financial
statements.
continued...
Page 6
BRITISH COCHLEAR IMPLANT GROUP CIO
Notes to the Financial Statements - continued
for the Year Ended 5 April 2024
2. OTHER TRADING ACTIVITIES
Sponsorships
3.
INVESTMENT INCOME
Deposit account interest
4.
RAISING FUNDS
Raising donations and legacies
Support costs
5.
TRUSTEES' REMUNERATION AND BENEFITS |
|
2024
£
-
2024
£
155
2024
£
- |
2023
£
3,000
2023
£
28
2023
£
25,369 |
2023
£
3,000 |
|
|
|
|
2023
£
28 |
|
|
|
|
|
Therewerenotrustees'remunerationorotherbenefitsfortheyearended5April2024norfor the
year ended 5 April 2023.
Trustees' expenses
Therewerenotrustees'expensespaidfortheyearended5April2024norfortheyear ended
5 April 2023.
6. COMPARATIVES FOR THE STATEMENT OF FINANCIAL ACTIVITIES
|
Unrestricted |
|
fund |
|
£ |
INCOME AND ENDOWMENTS FROM |
|
Donations and legacies |
31,781 |
Other trading activities |
3,000 |
Investment income |
28 |
Total |
34,809 |
EXPENDITURE ON |
|
Raising funds |
25,369 |
continued...
Page 7
BRITISH COCHLEAR IMPLANT GROUP CIO
Notes to the Financial Statements - continued
for the Year Ended 5 April 2024
6. COMPARATIVES FOR THE STATEMENT OF FINANCIAL ACTIVITIES - continued
|
|
|
|
Unrestricted |
|
|
|
|
fund |
|
|
|
|
£ |
|
Other |
|
|
36,191 |
|
Total |
|
|
61,560 |
|
NET INCOME/(EXPENDITURE) |
|
|
(26,751) |
|
RECONCILIATION OF FUNDS |
|
|
|
|
Total funds brought forward |
|
|
172,929 |
|
TOTAL FUNDS CARRIED FORWARD |
|
|
146,178 |
7. |
CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR |
|
|
|
|
|
|
2024 |
2023 |
|
|
|
£ |
£ |
|
Trade creditors |
|
834 |
686 |
8. |
MOVEMENT IN FUNDS |
|
|
|
|
|
|
Net |
|
|
|
|
movement |
|
|
|
At 6/4/23 |
in funds |
At 5/4/24 |
|
|
£ |
£ |
£ |
|
Unrestricted funds |
|
|
|
|
General fund |
146,178 |
(18,368) |
127,810 |
|
TOTAL FUNDS |
146,178 |
(18,368) |
127,810 |
continued...
Page 8
BRITISH COCHLEAR IMPLANT GROUP CIO
for the Year Ended 5 April 2024
Notes to the Financial Statements - continued
8. MOVEMENT IN FUNDS - continued
Net movement in funds, included in the above are as follows:
|
Incoming |
Resources |
Movement |
|
resources |
expended |
in funds |
|
£ |
£ |
£ |
Unrestricted funds |
|
|
|
General fund |
27,226 |
(45,594) |
(18,368) |
TOTAL FUNDS |
27,226 |
(45,594) |
(18,368) |
Comparatives for movement in funds
|
|
Net |
|
|
|
movement |
|
|
At 6/4/22 |
in funds |
At 5/4/23 |
|
£ |
£ |
£ |
Unrestricted funds |
|
|
|
General fund |
172,929 |
(26,751) |
146,178 |
TOTAL FUNDS |
172,929 |
(26,751) |
146,178 |
Comparative net movement in funds, included in the above are as follows:
|
Incoming |
Resources |
Movement |
|
resources |
expended |
in funds |
|
£ |
£ |
£ |
Unrestricted funds |
|
|
|
General fund |
34,809 |
(61,560) |
(26,751) |
TOTAL FUNDS |
34,809 |
(61,560) |
(26,751) |
continued...
Page 9
BRITISH COCHLEAR IMPLANT GROUP CIO
Notes to the Financial Statements - continued
for the Year Ended 5 April 2024
8. MOVEMENT IN FUNDS - continued
A current year 12 months and prior year 12 months combined position is as follows:
|
|
Net |
|
|
|
movement |
|
|
At 6/4/22 |
in funds |
At 5/4/24 |
|
£ |
£ |
£ |
Unrestricted funds |
|
|
|
General fund |
172,929 |
(45,119) |
127,810 |
TOTAL FUNDS |
172,929 |
(45,119) |
127,810 |
A currentyear12 monthsand prioryear12 monthscombinednet movementin funds,includedin the
above are as follows:
|
Incoming |
Resources |
Movement |
|
resources |
expended |
in funds |
|
£ |
£ |
£ |
Unrestricted funds |
|
|
|
General fund |
62,035 |
(107,154) |
(45,119) |
TOTAL FUNDS |
62,035 |
(107,154) |
(45,119) |
9. RELATED PARTY DISCLOSURES
There were no related party transactions for the year ended 5 April 2024.
Page 10
BRITISH COCHLEAR IMPLANT GROUP CIO
Detailed Statement of Financial Activities
for the Year Ended 5 April 2024
INCOME AND ENDOWMENTS
Donations and legacies
Subscriptions
Advertising Income
Other trading activities
Sponsorships
Investment income
Deposit account interest
Total incoming resources
EXPENDITURE
Other
Subscription costs
Travel & Meeting Expenses
Support costs
Management
Administration support
Insurance
Advertising and design
Sundries
Website & IT Support Fees
Finance
Bank charges
Governance costs
Accountancy and legal fees |
2024
£
25,821
1,250
27,071
-
155
27,226
9,000
2,027
11,027
19,239
154
2,744
1,773
9,823
33,733
-
834 |
2023
£
30,881
900 |
|
|
31,781
3,000
28 |
|
|
34,809
20,981
816 |
|
|
21,797
13,131
171
894
589
23,700 |
|
|
38,485
15
1,263 |
This page does not form part of the statutory financial statements
Page 11
BRITISH COCHLEAR IMPLANT GROUP CIO
Detailed Statement of Financial Activities
for the Year Ended 5 April 2024
Total resources expended
Net expenditure |
2024
£
45,594
(18,368) |
2023
£
61,560
(26,751) |
|
|
|
This page does not form part of the statutory financial statements
Page 12